Company / Cash & Equivalents
OneMedNet Corp Cash & Equivalents History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$585.0K
FY2025
5-year range
$172.0K / $585.0K
FY2023-FY2025
Trend
+240.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents changed +240% YoY in FY2025, a notable deviation from the 2-year average annual change of +99%.
Based on SEC 10-K filings.
$585,000 in FY2025.
Improved from $301,730 to $585,000 over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash & equivalents increased 240.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -14.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $585.0K | +240.1% |
| FY2024 | $172.0K | -43.0% |
| FY2023 | $301.7K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026